Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway

Regulatory Peptides

Volumn 169, Issue 1-3, 2011, Pages 13-20

  Ji, Hongli ^a,b   Meng, Ying ^a   Zhang, Xiaolan ^c   Luo, Wei ^a   Wu, Pingsheng ^a   Xiao, Bing ^a   Zhang, Zhenshu ^a   Li, Xu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Department of Oncology   (China)

^c Department of Senile Disease   (China)

Author keywords

Aldosterone; Cirrhosis; Contraction; Hepatic stellate cell; RhoA ROCK 2 signaling pathway

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALDOSTERONE; IRBESARTAN; MYOSIN LIGHT CHAIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPIRONOLACTONE;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; HORMONAL REGULATION; LIVER CIRRHOSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STELLATE CELL;

ALDOSTERONE; AMIDES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; CELL SIZE; CELLS, CULTURED; HEPATIC STELLATE CELLS; MALE; MYOSIN LIGHT CHAINS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SPIRONOLACTONE; STRESS FIBERS; TETRAZOLES;

RATTUS;

EID: 79958012845     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.04.010     Document Type: Article

References (39)

1. Cheng J.H., She H., Han Y.P., Wang J., Xiong S., Asahina K., Tsukamoto H. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008, 294:G39-G49.
2. Massimo P. Liver fibrosis. Springer Semin Immunopathol 2000, 21:475-490.
3. Reynaert H., Thompson M.G., Thomas T., Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 2002, 50:571-581.
4. Nagata D., Takahashi M., Sawai K., Tagami T., Usui T., Shimatsu A., Hirata Y., Naruse M. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 2006, 48:165-171.
5. McGrath M.F., de Bold A.J. Determinants of natriuretic peptide gene expression. Peptides 2005, 26:933-943.
6. Shapiro B.A., Olala L., Arun S.N., Parker P.M., George M.V., Bollag W.B. Angiotensin II-activated protein kinase D mediates acute aldosterone secretion. Mol Cell Endocrinol 2010, 317:99-105.
7. Taira M., Toba H., Murakami M., Iga I., Serizawa R., Murata S., Kobara M., Nakata T. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosteronesystem in diabetic rats. Eur J Pharmacol 2008, 589:264-271.
8. Ruilope L.M. Aldosterone, hypertension and cardiovascular disease: an endless story. Hypertension 2008, 52:207-208.
9. Delcayre C., Swynghedauw B. Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol 2002, 34:1577-1841.
10. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214:199-210.
11. Struthers A.D., MacDonald T.M. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 2004, 61:663-670.
12. Caligiuri A., De Franco R.M., Romanelli R.G., Gentilini A., Meucci M., Failli P., Mazzetti L., Rombouts K., Geerts A., Vanasia M., Gentilini P., Marra F., Pinzani M. Anti fibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology 2003, 124:504-520.
13. Kmieć Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001, 161:III-XIII. 1-151.
14. Li X., Meng Y., Wu P., Zhang Z., Yang X. Angiotensin II and aldosterone stimulating NF-ΚB and AP-1 activation in hepatic fibrosis of rat. Regul Pept 2007, 138:15-25.
15. Sakai H., Nishimura A., Watanabe Y., Nishizawa Y., Hashimoto Y., Chiba Y., Misawa M. Involvement of Src family kinase activation in angiotensin II-induced hyperresponsiveness of rat bronchial smooth muscle. Peptides 2010, 31:2216-2221.
16. Li L., Zhou Y., Wang C., Zhao Y.L., Zhang Z.G., Fan D., et al. Src tyrosine kinase regulates angiotensin II-induced protein kinase Czeta activation and proliferation in vascular smooth muscle cells. Peptides 2010, 31:1159-1164.
17. Rattan S., Puri R.N., Fan Y.P. Involvement of rho and rho-associated kinase in sphincteric smooth muscle contraction by angiotensin II. Exp Biol Med 2003, 228:972-981.
18. Liu C., Gaca M.D., Swenson E.S., Vellucci V.F., Reiss M., Wells R.G. Smads2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 2003, 278:11721-11728.
19. Yanase M., Ikeda H., Ogata I., Matsui A., Noiri E., Tomiya T., Arai M., Inoue Y., Tejima K., Nagashima K., Nishikawa T., Shibata M., Ikebe M., Rojkind M., Fujiwara K. Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line. Biochem Biophys Res Commun 2003, 305:223-228.
20. Ye Y., Hu S.J., Li L. Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway. FEBS Lett 2009, 583:2997-3003.
21. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635.
22. Zhou Q., Hennenberg M., Trebicka J., Jochem K., Leifeld L., Biecker E., Sauerbruch T., Heller J. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006, 55:1296-1305.
23. Hennenberg M., Biecker E., Trebicka J., Jochem K., Zhou Q., Schmidt M., Jakobs K.H., Sauerbruch T., Heller J. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology 2006, 130:838-854.
24. Yang X., Li X., Wu P., Meng Y., Li S., Lai W. CYP11B2 expression in rat liver and the effect of spironolactone on hepatic fibrogenesis. Horm Res 2000, 53:288-293.
25. Rombouts K., Niki T., Wielant A., Hellemans K., Schuppan D., Kormoss N., Geerts A. Effect of aldosterone on collagen steady state levels in primary and subcultured rat hepatic stellate cells. J Hepatol 2001, 34:230-238.
26. Ilagan R., Guthrie K., Quinlan S., Rapoport H.S., Jones S., Church A., Basu J., Ludlow J. Linear measurement of cell contraction in a capillary collagen gel system. Biotechniques 2010, 48:153-155.
27. Liu Z., van Grunsven L.A., Van Rossen E., Schroyen B., Timmermans J.P., Geerts A., Reynaert H. Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells. Br J Pharmacol 2010, 159:304-315.
28. Liu Y., Ko J.A., Yanai R., Kimura K., Chikama T., Sagara T., Nishida T. Induction by latanoprost of collagen gel contraction mediated by human tenon fibroblasts: role of intracellular signaling molecules. Invest Ophthalmol Vis Sci 2008, 49:1429-1436.
29. Kharbanda K.K., Rogers D.D., Wyatt T.A., Sorrell M.F., Tuma D.J. Transforming growth factor-b induces contraction of activated hepatic stellate cells. J Hepatol 2004, 41:60-66.
30. Yanase M., Ikeda H., Matsui A., Maekawa H., Noiri E., Tomiya T., Arai M., Yano T., Shibata M., Ikebe M., Fujiwara K., Rojkind M., Ogata I. Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with Rho-kinase. Biochem Biophys Res Commun 2000, 277:72-78.
31. Arora P.D., Narani N., McCulloch C.A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999, 154:871-882.
32. Hocking D.C., Sottile J., Langenbach K.J. Stimulation of integrin-mediated cell contractility by fibronectin polymerization. J Biol Chem 2000, 275:10673-10682.
33. Shen L., Black E.D., Witkowski E.D., Lencer W.I., Guerriero V., Schneeberger E.E., Turner J.R. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 2006, 119:2095-2106.
34. Brown N.J., Nakamura S., Ma L., Nakamura I., Donnert E., Freeman M., Vaughan D.E., Fogo A.B. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int 2000, 58:1219-1227.
35. Sohail M.A., Hashmi A.Z., Hakim W., Watanabe A., Zipprich A., Groszmann R.J., Dranoff J.A., Torok N.J., Mehal W.Z. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 2009, 49:185-194.
36. Touyz R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 2005, 90:449-455.
37. Montezano A.C., Callera G.E., Yogi A., He Y., Tostes R.C., He G., Schiffrin E.L., Touyz R.M. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol 2008, 28:1511-1518.
38. Savoia C., Tabet F., Yao G., Schiffrin E.L., Touyz R.M. Negative regulation of RhoA /Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 2005, 23:1037-1045.
39. Huang Z., Taylor L., Liu B., Yu J., Polgar P. Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1291-L1299.